<!DOCTYPE html><html lang="en"><head><meta charset="utf-8"/><meta http-equiv="X-UA-Compatible" content="IE=edge"/><meta name="viewport" content="width=device-width, initial-scale=1"/><title>Alice Morigi</title><link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/css/bootstrap.min.css"/><style>@font-face {
  font-family: 'icomoon';
  src:  url('fonts/icomoon.eot?z1lat9');
  src:  url('fonts/icomoon.eot?z1lat9#iefix') format('embedded-opentype'),
    url('fonts/icomoon.ttf?z1lat9') format('truetype'),
    url('fonts/icomoon.woff?z1lat9') format('woff'),
    url('fonts/icomoon.svg?z1lat9#icomoon') format('svg');
  font-weight: normal;
  font-style: normal;
}

[class^="icon-"], [class*=" icon-"] {
  /* use !important to prevent issues with browser extensions that change fonts */
  font-family: 'icomoon' !important;
  speak: none;
  font-style: normal;
  font-weight: normal;
  font-variant: normal;
  text-transform: none;
  line-height: 1;

  /* Better Font Rendering =========== */
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}

.icon-gitlab .path1:before {
  content: "\e906";
  color: rgb(252, 109, 38);
}
.icon-gitlab .path2:before {
  content: "\e907";
  margin-left: -1em;
  color: rgb(226, 67, 41);
}
.icon-gitlab .path3:before {
  content: "\e908";
  margin-left: -1em;
  color: rgb(252, 109, 38);
}
.icon-gitlab .path4:before {
  content: "\e909";
  margin-left: -1em;
  color: rgb(252, 163, 38);
}
.icon-gitlab .path5:before {
  content: "\e90a";
  margin-left: -1em;
  color: rgb(226, 67, 41);
}
.icon-gitlab .path6:before {
  content: "\e90b";
  margin-left: -1em;
  color: rgb(252, 109, 38);
}
.icon-gitlab .path7:before {
  content: "\e90c";
  margin-left: -1em;
  color: rgb(252, 163, 38);
}
.icon-gitlab .path8:before {
  content: "\e90d";
  margin-left: -1em;
  color: rgb(226, 67, 41);
}
.icon-meetup .path1:before {
  content: "\e901";
  color: rgb(255, 255, 255);
}
.icon-meetup .path2:before {
  content: "\e902";
  margin-left: -1.5em;
  color: rgb(240, 1, 1);
}
.icon-meetup .path3:before {
  content: "\e903";
  margin-left: -1.5em;
  color: rgb(3, 3, 3);
}
.icon-blogger:before {
  content: "\e900";
}
.icon-exercism:before {
  content: "\e601";
}
.icon-telegram:before {
  content: "\e904";
}
.icon-flickr:before {
  content: "\f16e";
}
.icon-medium:before {
  content: "\f23a";
}
.icon-heart:before {
  content: "\f004";
}
.icon-book:before {
  content: "\f02d";
}
.icon-linkedin:before {
  content: "\f08c";
}
.icon-twitter:before {
  content: "\f099";
}
.icon-github:before {
  content: "\f09b";
}
.icon-link:before {
  content: "\f0c1";
}
.icon-bars:before {
  content: "\f0c9";
}
.icon-pinterest:before {
  content: "\f0d2";
}
.icon-googleplus:before {
  content: "\f0d5";
}
.icon-circle:before {
  content: "\f111";
}
.icon-code:before {
  content: "\f121";
}
.icon-youtube:before {
  content: "\f167";
}
.icon-stackoverflow:before {
  content: "\f16c";
}
.icon-bitbucket:before {
  content: "\f171";
}
.icon-tumblr:before {
  content: "\f173";
}
.icon-dribbble:before {
  content: "\f17d";
}
.icon-skype:before {
  content: "\f17e";
}
.icon-foursquare:before {
  content: "\f180";
}
.icon-gittip:before {
  content: "\f184";
}
.icon-gratipay:before {
  content: "\f184";
}
.icon-stackexchange:before {
  content: "\f18d";
}
.icon-vimeo:before {
  content: "\f194";
}
.icon-graduation-cap:before {
  content: "\f19d";
}
.icon-language:before {
  content: "\f1ab";
}
.icon-child:before {
  content: "\f1ae";
}
.icon-behance:before {
  content: "\f1b5";
}
.icon-spotify:before {
  content: "\f1bc";
}
.icon-soundcloud:before {
  content: "\f1be";
}
.icon-codepen:before {
  content: "\f1cb";
}
.icon-hackernews:before {
  content: "\f1d4";
}
.icon-lastfm:before {
  content: "\f202";
}
.icon-angellist:before {
  content: "\f209";
}
.icon-facebook:before {
  content: "\f230";
}
.icon-instagram:before {
  content: "\e905";
}
.icon-trophy:before {
  content: "\e605";
}
.icon-office:before {
  content: "\e606";
}
.icon-clock:before {
  content: "\e60a";
}
.icon-reddit:before {
  content: "\e609";
}
.icon-profile:before {
  content: "\e600";
}
.icon-tools:before {
  content: "\e034";
}
.icon-location:before {
  content: "\e602";
}
.icon-mail:before {
  content: "\e603";
}
.icon-phone:before {
  content: "\e03f";
}
.icon-newspaper:before {
  content: "\e607";
}
.icon-chevron-down:before {
  content: "\e60c";
}
.icon-chevron-up:before {
  content: "\e60d";
}
.icon-dots-three-horizontal:before {
  content: "\e60b";
}
.icon-thumbs-up:before {
  content: "\e604";
}
.icon-board:before {
  content: "\e608";
}

.relative {
  position: relative;
}
.clear-margin {
  margin: 0;
}
.space-top {
  margin-top: 10px;
}
.space-right {
  margin-right: 10px;
}
.space-bottom {
  margin-bottom: 10px;
}
.mr-5 {
  margin-right: 5px;
}
.mr-10 {
  margin-right: 10px;
}
.ml-5 {
  margin-left: 5px;
}
.labels {
  line-height: 2;
}
.label-keyword {
  display: inline-block;
  background: #7eb0db;
  color: white;
  font-size: 0.9em;
  padding: 5px;
  border: 1px solid #357ebd;
  margin-right: 5px;
}
.label-keyword:last-child {
  margin-right: 0;
}
.label-keyword p {
  margin: 0;
}
.label-keyword a {
  color: white;
}
.label-keyword a:hover {
  text-decoration: none;
}
.link-disguise {
  color: inherit;
}
.link-disguise:hover {
  color: inherit;
}
.clear-margin {
  margin: 0;
}
@media (max-width: 992px) {
  .clear-margin-sm {
    margin-bottom: 0;
  }
}
.fs-lg {
  font-size: 1.33333333em;
  line-height: 0.75em;
  vertical-align: -15%;
}
.fs-2x {
  font-size: 2em;
}
.fs-3x {
  font-size: 3em;
}
.fs-4x {
  font-size: 4em;
}
.btn-circle-sm {
  width: 28px;
  height: 28px;
  line-height: 28px;
  border-radius: 50%;
  text-align: center;
  padding: 0;
  outline: none !important;
}
/* the version when the icon file is last updated */
@font-face {
  font-family: 'jst-elegant';
  src: url("//unpkg.com/jsonresume-theme-elegant@1.12.0/assets/icomoon/fonts/icomoon.eot?f218wo");
  src: url("//unpkg.com/jsonresume-theme-elegant@1.12.0/assets/icomoon/fonts/icomoon.eot?f218wo#iefix") format('embedded-opentype'), url("//unpkg.com/jsonresume-theme-elegant@1.12.0/assets/icomoon/fonts/icomoon.ttf?f218wo") format('truetype'), url("//unpkg.com/jsonresume-theme-elegant@1.12.0/assets/icomoon/fonts/icomoon.woff?f218wo") format('woff'), url("//unpkg.com/jsonresume-theme-elegant@1.12.0/assets/icomoon/fonts/icomoon.svg?f218wo#icomoon") format('svg');
  font-weight: normal;
  font-style: normal;
}
[class^="icon-"],
[class*=" icon-"] {
  /* use !important to prevent issues with browser extensions that change fonts */
  font-family: 'jst-elegant' !important;
}
body {
  font-family: 'Lato';
  background: #f0f0f0;
  color: #333;
}
.main {
  padding: 5px;
}
.card {
  background: white;
  border: 1px solid #e6e6e6;
  border-radius: 3px;
  min-height: 300px;
  padding: 10px 0;
}
.card-nested {
  min-height: 0;
  border-width: 1px 0 0 0;
}
.card-nested:before,
.card-nested:after {
  content: " ";
  display: table;
}
.card-nested:after {
  clear: both;
}
@media (max-width: 480px) {
  .card-nested {
    padding: 5px 0;
  }
}
.background-card {
  padding: 10px 20px;
}
.card-wrapper {
  padding: 5px;
}
@media (max-width: 992px) {
  .card-wrapper {
    float: none !important;
  }
}
.background-details .detail {
  display: table;
}
.background-details .detail .icon {
  min-width: 45px;
  max-width: 45px;
  text-align: center;
}
.background-details .detail .info {
  width: 100%;
}
.background-details .detail .title,
.background-details .detail .icon {
  color: #707070;
}
.background-details .detail .mobile-title {
  display: none;
}
@media (max-width: 480px) {
  .background-details .detail .mobile-title {
    display: inline-block;
    margin-left: 5px;
    font-weight: bold;
    text-transform: uppercase;
    vertical-align: middle;
  }
}
.background-details .detail .icon,
.background-details .detail .info {
  display: table-cell;
  padding: 0 10px;
}
@media (max-width: 480px) {
  .background-details .detail {
    display: block;
  }
  .background-details .detail .icon {
    max-width: inherit;
    min-width: inherit;
    text-align: left;
  }
  .background-details .detail .icon,
  .background-details .detail .info {
    display: block;
    padding: 10px 0;
  }
  .background-details .detail .title {
    display: none;
  }
}
.info .content.has-sidebar {
  width: 80%;
  box-sizing: border-box;
  float: left;
  padding: 0 10px;
  border-right: 1px solid #cdcdcd;
}
@media (max-width: 992px) {
  .info .content.has-sidebar {
    width: 100%;
    border-right: 0;
  }
}
@media (max-width: 480px) {
  .info .content.has-sidebar {
    padding: 0 2px;
  }
}
.info .sidebar {
  margin-left: 80%;
  box-sizing: border-box;
  padding: 10px;
}
@media (max-width: 480px) {
  ul {
    padding-left: 25px;
  }
}
.current-event {
  font-size: 8px;
  color: #5ACE24;
  position: absolute;
  right: 100%;
  top: 4px;
  left: -10px;
}
.mop-wrapper > p:last-child {
  margin: 0;
}
/*
    Credits: http://codyhouse.co/demo/smart-fixed-navigation/index.html
*/
.floating-nav-trigger {
  width: 50px;
  height: 50px;
  -webkit-box-shadow: 0 1px 4px rgba(0, 0, 0, 0.24);
  box-shadow: 0 1px 4px rgba(0, 0, 0, 0.24);
  -webkit-transition: background-color 0.5s ease;
  -o-transition: background-color 0.5s ease;
  transition: background-color 0.5s ease;
  display: block;
  border-radius: 50%;
  text-align: center;
  background-color: white;
  font-size: 1.5em;
  color: #357ebd;
  z-index: 100;
  position: fixed;
  bottom: 10px;
  right: 10px;
  text-decoration: none !important;
}
.floating-nav-trigger > [class^="icon-"],
.floating-nav-trigger [class*=" icon-"],
.floating-nav-trigger > .close-icon {
  line-height: 50px;
}
.floating-nav-trigger .close-icon {
  display: none;
}
.floating-nav-trigger:hover {
  color: #1f496e;
  background-color: #e6e6e6;
}
.floating-nav-trigger.is-open {
  -webkit-box-shadow: none;
  box-shadow: none;
}
.floating-nav-trigger.is-open .close-icon {
  display: inherit;
}
.floating-nav-trigger.is-open .icon-bars {
  display: none;
}
.floating-nav-trigger.is-open:hover {
  background-color: white;
}
.floating-nav {
  -webkit-transform: scale(0);
  -ms-transform: scale(0);
  -o-transform: scale(0);
  transform: scale(0);
  -webkit-transform-origin: 100% 100%;
  -moz-transform-origin: 100% 100%;
  -ms-transform-origin: 100% 100%;
  transform-origin: 100% 100%;
  -webkit-transition: transform 0.3s, visibility 0s 0.3s;
  -o-transition: transform 0.3s, visibility 0s 0.3s;
  transition: transform 0.3s, visibility 0s 0.3s;
  -webkit-box-shadow: 0 1px 4px rgba(0, 0, 0, 0.24);
  box-shadow: 0 1px 4px rgba(0, 0, 0, 0.24);
  position: fixed;
  z-index: 50;
  right: 10px;
  bottom: 10px;
  background-color: white;
  width: 90%;
  max-width: 400px;
  visibility: hidden;
  overflow: hidden;
}
.floating-nav ul {
  font-size: 1.2em;
  margin: 0;
}
.floating-nav ul li {
  border-bottom: 1px solid #eff2f6;
}
.floating-nav ul li a {
  padding: 20px;
  text-decoration: none;
  color: #357ebd;
  display: block;
}
.floating-nav ul li a:hover {
  color: #1f496e;
}
.floating-nav ul li:last-child {
  border-bottom: 0;
}
.floating-nav.is-visible {
  -webkit-transform: scale(1);
  -ms-transform: scale(1);
  -o-transform: scale(1);
  transform: scale(1);
  -webkit-transition: transform 0.3s, visibility 0s 0s;
  -o-transition: transform 0.3s, visibility 0s 0s;
  transition: transform 0.3s, visibility 0s 0s;
  visibility: visible;
}
@media (max-width: 992px) {
  .profile-card-wrapper {
    position: relative;
  }
}
.profile-card-wrapper .profile-card {
  padding: 10px;
}
.profile-pic {
  padding: 20px 0;
}
@media (max-width: 992px) {
  .profile-pic {
    padding: 10px 0;
  }
}
.profile-pic img {
  width: 100px;
  height: 100px;
}
@media (max-width: 992px) {
  .name {
    margin-top: 10px;
  }
}
@media (max-width: 768px) {
  .contact-details {
    text-align: center;
  }
}
.contact-details .detail {
  display: table;
  padding: 10px 0;
}
.contact-details .detail .icon {
  padding: 0 10px;
  color: #707070;
}
@media (max-width: 992px) {
  .contact-details .detail .icon {
    padding: 0 5px 0 0;
  }
}
.contact-details .detail .info {
  font-size: 0.8em;
}
.contact-details .detail .icon,
.contact-details .detail .info {
  display: table-cell;
  vertical-align: middle;
}
@media (max-width: 768px) {
  .contact-details .detail {
    position: relative;
    float: left;
    width: 100%;
    min-height: 1px;
    padding-left: 15px;
    padding-right: 15px;
  }
}
@media (max-width: 992px) {
  .contact-details .detail {
    position: relative;
    min-height: 1px;
    padding-left: 15px;
    padding-right: 15px;
    padding: 10px;
  }
  .contact-details .detail .icon,
  .contact-details .detail .info {
    display: inline-block;
  }
}
@media (max-width: 992px) and (min-width: 768px) {
  .contact-details .detail {
    float: left;
    width: 25%;
  }
}
.social-links {
  line-height: 2.5;
}
.social-link {
  margin-left: 5px;
  min-width: 35px;
  display: inline-block;
}
.social-link:first-child {
  margin-left: 0;
}
.social-link:hover {
  text-decoration: none;
}
.link-github {
  color: #454545;
}
.link-github:hover,
.link-github:focus {
  text-decoration: none;
  color: #2b2b2b;
}
.link-twitter {
  color: #33ccff;
}
.link-twitter:hover,
.link-twitter:focus {
  text-decoration: none;
  color: #00bfff;
}
.link-blog {
  color: #f36f24;
}
.link-blog:hover,
.link-blog:focus {
  text-decoration: none;
  color: #d8560c;
}
.link-linkedin {
  color: #007bb6;
}
.link-linkedin:hover,
.link-linkedin:focus {
  text-decoration: none;
  color: #005983;
}
.link-skype {
  color: #12A5F4;
}
.link-skype:hover,
.link-skype:focus {
  text-decoration: none;
  color: #0986ca;
}
.link-instagram {
  color: #e4405f;
}
.link-instagram:hover,
.link-instagram:focus {
  text-decoration: none;
  color: #d31e40;
}
.link-stackoverflow {
  color: #8e8e92;
}
.link-stackoverflow:hover,
.link-stackoverflow:focus {
  text-decoration: none;
  color: #747479;
}
.link-stackexchange {
  color: #62b0df;
}
.link-stackexchange:hover,
.link-stackexchange:focus {
  text-decoration: none;
  color: #389bd6;
}
.link-lastfm {
  color: #d12127;
}
.link-lastfm:hover,
.link-lastfm:focus {
  text-decoration: none;
  color: #a51a1f;
}
.link-soundcloud {
  color: #e8822d;
}
.link-soundcloud:hover,
.link-soundcloud:focus {
  text-decoration: none;
  color: #cc6916;
}
.link-googleplus {
  color: #dd4b39;
}
.link-googleplus:hover,
.link-googleplus:focus {
  text-decoration: none;
  color: #c23321;
}
.link-youtube {
  color: #dd4b39;
}
.link-youtube:hover,
.link-youtube:focus {
  text-decoration: none;
  color: #c23321;
}
.link-pinterest {
  color: #bd091f;
}
.link-pinterest:hover,
.link-pinterest:focus {
  text-decoration: none;
  color: #8c0717;
}
.link-gratipay {
  color: #630;
}
.link-gratipay:hover,
.link-gratipay:focus {
  text-decoration: none;
  color: #331a00;
}
.link-vimeo {
  color: #17b3e8;
}
.link-vimeo:hover,
.link-vimeo:focus {
  text-decoration: none;
  color: #128fba;
}
.link-behance {
  color: #2c98cf;
}
.link-behance:hover,
.link-behance:focus {
  text-decoration: none;
  color: #2379a5;
}
.link-codepen {
  color: #1c1c1c;
}
.link-codepen:hover,
.link-codepen:focus {
  text-decoration: none;
  color: #020202;
}
.link-foursquare {
  color: #fa4778;
}
.link-foursquare:hover,
.link-foursquare:focus {
  text-decoration: none;
  color: #f91554;
}
.link-reddit {
  color: #545454;
}
.link-reddit:hover,
.link-reddit:focus {
  text-decoration: none;
  color: #3b3b3b;
}
.link-spotify {
  color: #acd200;
}
.link-spotify:hover,
.link-spotify:focus {
  text-decoration: none;
  color: #829f00;
}
.link-tumblr {
  color: #2d4661;
}
.link-tumblr:hover,
.link-tumblr:focus {
  text-decoration: none;
  color: #1d2d3e;
}
.link-dribbble {
  color: #ce366f;
}
.link-dribbble:hover,
.link-dribbble:focus {
  text-decoration: none;
  color: #a82959;
}
.link-facebook {
  color: #4b6daa;
}
.link-facebook:hover,
.link-facebook:focus {
  text-decoration: none;
  color: #3b5687;
}
.link-angellist {
  color: black;
}
.link-angellist:hover,
.link-angellist:focus {
  text-decoration: none;
  color: #000000;
}
.link-bitbucket {
  color: #205081;
}
.link-bitbucket:hover,
.link-bitbucket:focus {
  text-decoration: none;
  color: #163758;
}
.link-hackernews {
  color: #ff6600;
}
.link-hackernews:hover,
.link-hackernews:focus {
  text-decoration: none;
  color: #cc5200;
}
.link-exercism {
  color: #d81d4e;
}
.link-exercism:hover,
.link-exercism:focus {
  text-decoration: none;
  color: #ab173e;
}
.link-blogger {
  color: #FF9234;
}
.link-blogger:hover,
.link-blogger:focus {
  text-decoration: none;
  color: #ff7701;
}
.link-medium {
  color: #00AB6C;
}
.link-medium:hover,
.link-medium:focus {
  text-decoration: none;
  color: #00784c;
}
.link-flickr {
  color: black;
}
.link-flickr:hover,
.link-flickr:focus {
  text-decoration: none;
  color: #000000;
}
.link-telegram {
  color: #3BABDD;
}
.link-telegram:hover,
.link-telegram:focus {
  text-decoration: none;
  color: #2291c3;
}
.card-skills {
  position: relative;
}
.skill-level {
  border-radius: 3px;
  position: absolute;
  top: 10px;
  bottom: 10px;
  left: 0;
  width: 10px;
  box-shadow: inset 0 0 1px rgba(0, 0, 0, 0.2);
}
.skill-level .skill-progress {
  position: absolute;
  border-radius: 3px;
  bottom: 0;
  width: 100%;
  -webkit-transition: height 1s ease;
}
.skill-level .skill-progress.beginner {
  height: 50%;
  background: #e74c3c;
}
.skill-level .skill-progress.intermediate {
  height: 70%;
  background: #f1c40f;
}
.skill-level .skill-progress.advanced {
  height: 80%;
  background: #428bca;
}
.skill-level .skill-progress.master {
  height: 95%;
  background: #5cb85c;
}
.skill-info {
  margin-left: 15px;
}
@media (max-width: 480px) {
  .skill-info {
    margin-left: 20px;
  }
}
@media (max-width: 768px) {
  .quote {
    font-size: inherit;
  }
}
.icon-meetup .path2:before {
  margin-left: 0;
}
@media print {
  a[href]:after {
    content: none !important;
  }
  .profile-card {
    text-align: center;
  }
  .profile-pic {
    display: inline-block;
    vertical-align: middle;
  }
  .profile-pic img {
    border-radius: 0;
  }
  .name-and-profession {
    display: inline-block;
    vertical-align: middle;
    margin-left: 15px;
  }
  .contact-details .detail {
    position: relative;
    float: left;
    width: 25%;
    min-height: 1px;
    padding-left: 15px;
    padding-right: 15px;
    padding: 0;
  }
  .floating-nav,
  .floating-nav-trigger {
    display: none;
  }
  .pagebreak {
    page-break-before: always;
  }
}
</style></head><body itemscope="itemscope" itemtype="http://schema.org/Person"><div class="container-fluid"><div class="row main clearfix"><a class="js-floating-nav-trigger floating-nav-trigger" href="#"><i class="icon-bars"></i><span class="close-icon">&times;</span></a><nav class="floating-nav js-floating-nav"><ul class="list-unstyled"><li><a href="#about"><i class="mr-10 icon-board"></i>About</a></li><li><a href="#work-experience"><i class="mr-10 icon-office"></i>Work Experience</a></li><li><a href="#education"><i class="mr-10 icon-graduation-cap"></i>Education</a></li><li><a href="#awards"><i class="mr-10 icon-trophy"></i>Awards</a></li><li><a href="#publications"><i class="mr-10 icon-newspaper"></i>Publications</a></li></ul></nav><section class="col-md-3 card-wrapper profile-card-wrapper affix"><div class="card profile-card"><span class="profile-pic-container"><div class="profile-pic"><img class="media-object img-circle center-block" data-src="holder.js/100x100" alt="Alice Morigi" src="https://s.gravatar.com/avatar/2f2ab9ebd4325b0d30ee3b366cc100e4?s=100&amp;r=pg&amp;d=mm" itemprop="image"/></div><div class="name-and-profession text-center"><h3 itemprop="name"><b>Alice Morigi</b></h3><h5 class="text-muted" itemprop="jobTitle">Hematologist Specialist</h5></div></span><hr/><div class="contact-details clearfix"><div class="detail"><span class="icon"><i class="icon fs-lg icon-location"></i></span><span class="info">Via De' Carracci 69/22, Bologna, Emilia-Romagna, IT, 40129</span></div><div class="detail"><span class="icon"><i class="icon fs-lg icon-mail"></i></span><span class="info"><a class="link-disguise" href="mailto:alice.m04@gmail.com" itemprop="email">alice.m04@gmail.com</a></span></div><div class="detail"><span class="icon" title="Languages I speak"><i class="icon fs-lg icon-language"></i></span><span class="info">Italian, English</span></div></div><hr/><div class="social-links text-center"><div></div></div></div></section><section class="col-md-9 card-wrapper pull-right"><div class="card background-card"><h4 class="text-uppercase">Background</h4><hr/><div class="background-details"><div class="detail" id="about"><div class="icon"><i class="fs-lg icon-board"></i><span class="mobile-title">About</span></div><div class="info"><h4 class="title text-uppercase">About</h4><div class="card card-nested"><div class="content mop-wrapper" itemprop="description"><p>I am a highly accomplished hematologist with a strong background in research and clinical practice and extensive experience as a sub-investigator in over 40 active clinical trials across phases 1 to 4. I specialize in hematology and oncology, focusing on innovative treatments for hematologic malignancies, particularly within the realm of lymphoproliferative disorders.</p>
</div></div></div></div><div class="detail" id="work-experience"><div class="icon"><i class="fs-lg icon-office"></i><span class="mobile-title">Work Experience</span></div><div class="info"><h4 class="title text-uppercase">Work Experience</h4><ul class="list-unstyled clear-margin"><li class="card card-nested clearfix"><div class="content"><p class="clear-margin relative"><i class="icon-circle current-event" rel="tooltip" title="Currently Working" data-placement="left"></i><strong>Research Fellow</strong>,&nbsp;Alma Mater Studiorum - University of Bologna - Department of Diagnostic and Experimental Specialist Medicine (DIMES)</p><p class="text-muted"><small><span class="space-right">Nov, 2020 - Present</span></small></p><div class="mop-wrapper space-bottom"></div><ul><li class="mop-wrapper"><p>Project: Management of patients with lymphoma enrolled in clinical trials and treated with checkpoint inhibitors</p>
</li></ul></div></li><li class="card card-nested clearfix"><div class="content"><p class="clear-margin relative"><i class="icon-circle current-event" rel="tooltip" title="Currently Working" data-placement="left"></i><strong>PhD in Oncology, Hematology and Pathology</strong>,&nbsp;Alma Mater Studiorum - University of Bologna - Institute of Medical Hematology and Oncology 'L. Seragnoli'</p><p class="text-muted"><small><span class="space-right">Nov, 2019 - Present</span></small></p><div class="mop-wrapper space-bottom"><p>XXXV Cycle. Scientific disciplinary field MED/15 Blood Diseases.</p>
</div><ul><li class="mop-wrapper"><p>Project: Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma</p>
</li></ul></div></li><li class="card card-nested clearfix"><div class="content"><p class="clear-margin relative"><strong>Residency in Hematology</strong>,&nbsp;Alma Mater Studiorum - University of Bologna - Institute of Medical Hematology and Oncology 'L. Seragnoli'</p><p class="text-muted"><small><span class="space-right">Nov, 2015 - Oct, 2020</span><span><i class="icon-clock mr-5"></i>4 years 11 months</span></small></p><div class="mop-wrapper space-bottom"></div><ul><li class="mop-wrapper"><p>Thesis: Role of fludarabine containing regimen in the first line treatment of non Hodgkin indolente non follicular Lymphoma: the Bologna experience in 143 patients</p>
</li></ul></div></li><li class="card card-nested clearfix"><div class="content"><p class="clear-margin relative"><strong>Pre-residency Internship in Hematology</strong>,&nbsp;Alma Mater Studiorum - University of Bologna - Institute of Medical Hematology and Oncology 'L. Seragnoli'</p><p class="text-muted"><small><span class="space-right">Jul, 2014 - Aug, 2015</span><span><i class="icon-clock mr-5"></i>1 year 1 month</span></small></p><div class="mop-wrapper space-bottom"></div></div></li><li class="card card-nested clearfix"><div class="content"><p class="clear-margin relative"><strong>Internship</strong>,&nbsp;Alma Mater Studiorum - University of Bologna - Institute of Medical Hematology and Oncology 'L. Seragnoli'</p><p class="text-muted"><small><span class="space-right">Oct, 2014 - Jul, 2014</span><span><i class="icon-clock mr-5"></i>2 months</span></small></p><div class="mop-wrapper space-bottom"></div></div></li></ul></div></div><div class="detail" id="education"><div class="icon"><i class="fs-lg icon-graduation-cap"></i><span class="mobile-title">Education</span></div><div class="info"><h4 class="title text-uppercase">Education</h4><div class="content"><ul class="list-unstyled clear-margin"><li class="card card-nested"><div class="content"><p class="clear-margin relative"><strong>Advanced Cardiovascular Life Support (ACLS) Program, Specialization,&nbsp;</strong>American Heart Association</p><p class="text-muted clear-margin"><small>Dec, 2023 - Dec, 2023</small></p><i></i></div></li><li class="card card-nested"><div class="content"><p class="clear-margin relative"><i class="icon-circle current-event" rel="tooltip" title="Currently Pursuing" data-placement="left"></i><strong>Oncology, Hematology and Pathology, XXXV Cycle, PhD,&nbsp;</strong>Alma Mater Studiorum - University of Bologna - Institute of Medical Hematology and Oncology 'L. Seragnoli'</p><p class="text-muted"><small>Nov, 2019 - Present</small></p><i></i><div class="space-top labels"><span class="label label-keyword"><p>Project: Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma</p>
</span></div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin relative"><strong>Hematology, Medical Specialization,&nbsp;</strong>Alma Mater Studiorum - University of Bologna</p><p class="text-muted"><small>Oct, 2015 - Oct, 2020</small></p><i></i><div class="space-top labels"><span class="label label-keyword"><p>Thesis: Efficacy of chemotherapy after checkpoint inhibitors in classical Hodgkin lymphoma: Experience from the L.A. Seràgnoli Institute</p>
</span></div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin relative"><strong>License to practice Medicine, Certificate,&nbsp;</strong>Medical Doctors, Surgeons and Orthodontists Association of Ravenna</p><p class="text-muted clear-margin"><small>Feb, 2015 - Feb, 2015</small></p><i></i></div></li><li class="card card-nested"><div class="content"><p class="clear-margin relative"><strong>Medicine and Surgery, Specialistic Degree,&nbsp;</strong>Alma Mater Studiorum - University of Bologna</p><p class="text-muted"><small>Oct, 2008 - Jul, 2014</small></p><i></i><div class="space-top labels"><span class="label label-keyword"><p>Thesis: Role of fludarabine containing regimen in the first line treatment of non Hodgkin indolente non follicular Lymphoma: the Bologna experience in 143 patients</p>
</span></div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin relative"><strong>Scientific, High School Diploma,&nbsp;</strong>Liceo Scientifico Statale “G. Ricci Curbastro”, Lugo (RA)</p><p class="text-muted clear-margin"><small>Sep, 2003 - Jul, 2008</small></p><i></i></div></li></ul></div></div></div><div class="detail" id="awards"><div class="icon"><i class="fs-lg icon-trophy"></i><span class="mobile-title">Awards</span></div><div class="info"><h4 class="title text-uppercase">Awards</h4><div class="content"><ul class="list-unstyled clear-margin"><li class="card card-nested"><div class="content"><p class="clear-margin" itemprop="award"><strong>Speaker </strong>,&nbsp;46° Congresso Nazionale SIE</p><p class="text-muted"><small>Awarded on: Oct 01, 2017</small></p><div class="mop-wrapper"><p>Efficacy and tolerability of Ibrutinib in relapsed/refractory mantle cell lymphoma under compassionate use: Results from real-world clinical practice</p>
</div></div></li></ul></div></div></div><div class="detail" id="publications"><div class="icon"><i class="fs-lg icon-newspaper"></i><span class="mobile-title">Publications</span></div><div class="info"><h4 class="title text-uppercase">Publications</h4><div class="content"><ul class="list-unstyled clear-margin"><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report, </strong>Chemotherapy</p><p class="text-muted"><small>Published on: Jun 01, 2023</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Gentilini M., Casadei B., Morigi A., Lolli G., Ferrari M., Carella M., Argnani L., Zinzani P.L.</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series, </strong>Tumori</p><p class="text-muted"><small>Published on: Apr 01, 2022</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A., Argnani L., Coppola P.E., Gentilini M., Bagnato G., Lolli G., Carella M., Nanni L., Morigi A., Casadei B., Pellegrini C., Stefoni V., Zinzani P.L.</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience, </strong>J Cancer Res Clin Oncol</p><p class="text-muted"><small>Published on: Mar 01, 2022</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Stefoni V, Argnani L, Carella M, Casadei B, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Coppola PE, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, </strong>Hematol Oncol</p><p class="text-muted"><small>Published on: Feb 01, 2022</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A, Terragna C, Nanni L, Martello M, Armuzzi S, Agostinelli C, Morigi A, Casadei B, Pellegrini C, Stefoni V, Sabattini E, Argnani L, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience, </strong>J Clin Med</p><p class="text-muted"><small>Published on: Dec 01, 2021</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A, Argnani L, Morigi A, Nanni L, Casadei B, Pellegrini C, Stefoni V, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience, </strong>Am J Hematol</p><p class="text-muted"><small>Published on: Oct 01, 2021</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A, Argnani L, Nanni L, Terragna C, Sabattini E, Gabrielli G, Stefoni V, Pellegrini C, Casadei B, Morigi A, Lolli G, Carella M, Coppola PE, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience, </strong>Cancers (Basel)</p><p class="text-muted"><small>Published on: Sep 01, 2021</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Casadei B, Argnani L, Guadagnuolo S, Pellegrini C, Stefoni V, Broccoli A, Nanni L, Morigi A, Lolli G, Guarino M, Spinardi L, Pierucci E, Fanti S, Bartoletti M, Dicataldo M, Sabattini E, Bonifazi F, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients, </strong>Ann Hematol</p><p class="text-muted"><small>Published on: Sep 01, 2021</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Casadei B, Argnani L, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Stefoni V, Coppola PE, Carella M, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation, </strong>Clin Lymphoma Myeloma Leuk</p><p class="text-muted"><small>Published on: Aug 01, 2021</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Morigi A, Stefoni V, Argnani L, Broccoli A, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma, </strong>Leuk Lymphoma</p><p class="text-muted"><small>Published on: Apr 01, 2021</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Morigi A, Casadei B, Argnani L, Stefoni V, Sergio E, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience, </strong>Hematol Oncol</p><p class="text-muted"><small>Published on: Sep 01, 2020</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Casadei B, Argnani L, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Stefoni V, Coppola PE, Carella M, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma, </strong>Cancer Med</p><p class="text-muted"><small>Published on: Sep 01, 2020</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Casadei B, Argnani L, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Stefoni V, Coppola PE, Carella M, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients, </strong>Hematol Oncol</p><p class="text-muted"><small>Published on: Jun 01, 2020</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Morigi A, Argnani L, Lolli G, Broccoli A, Pellegrini C, Nanni L, Stefoni V, Coppola PE, Carella M, Casadei B, Sabattini E, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>90 Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study, </strong>Br J. Haematol</p><p class="text-muted"><small>Published on: Apr 01, 2020</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Lolli G., Argnani L., Broccoli A., Marangon M., Pellegrini C., Morigi A., Casadei B., Nanni L., Stefoni V., Carella M., Cavo M., Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Spontaneous remission of follicular lymphoma, </strong>Hematol Oncol</p><p class="text-muted"><small>Published on: Dec 01, 2019</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Morigi A, Casadei B, Argnani L, Cavo M1, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series, </strong>Haematologica</p><p class="text-muted"><small>Published on: Nov 01, 2019</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Casadei B, Broccoli A, Stefoni V, Pellegrini C, Marangon M, Morigi A, Nanni L, Lolli G, Carella M, Argnani L, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia, </strong>Onco Targets Ther</p><p class="text-muted"><small>Published on: Jun 01, 2019</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A, Bertuzzi C, Fiorentino M, Morigi A, Stefoni V, Agostinelli C, Argnani L, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies, </strong>Hematol Oncol</p><p class="text-muted"><small>Published on: Jan 01, 2019</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Nanni L, Morigi A, Casadei B, Broccoli A, Stefoni V, Argnani L, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Granulomatous tattoo reaction in a nivolumab-treated patient, </strong>G Ital Dermatol Venereol</p><p class="text-muted"><small>Published on: Jun 01, 2018</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Pileri A, Starace M, Leuzzi M, Agostinelli C, Sabattini E, Morigi A, Zinzani PL, Patrizi A</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience, </strong>Am J Hematol</p><p class="text-muted"><small>Published on: Jun 01, 2018</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Marangon M, Tonialini L, Morigi A, Stefoni V, Broccoli A, Pellegrini C, Casadei B, Argnani L, Cavo M, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma, </strong>Oncotarget</p><p class="text-muted"><small>Published on: May 01, 2018</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A, Casadei B, Morigi A, Sottotetti F, Gotti M, Spina M, Volpetti S, Ferrero S, Spina F,Pisani F, Merli M, Visco C, Paolini R, Zilioli VR, Baldini L, Di Renzo N, Tosi P, Cascavilla N, Molica S, Ilariucci F, Rigolin GM, D'Alò F, Vanazzi A, Santambrogio E, Marasca R, Mastrullo L, Castellino C, Desabbata G, Scortechini I, Trentin L, Morello L, Argnani L, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients, </strong>BMC Cancer</p><p class="text-muted"><small>Published on: Apr 01, 2017</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Broccoli A, Casadei B, Stefoni V, Pellegrini C, Quirini F, Tonialini L, Morigi A, Marangon M, Argnani L, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients, </strong>Oncologist</p><p class="text-muted"><small>Published on: Dec 01, 2016</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Gandolfi L, Pellegrini C, Casadei B, Stefoni V, Broccoli A, Tonialini L, Morigi A, Argnani L, Zinzani PL</p>
</div></div></li><li class="card card-nested"><div class="content"><p class="clear-margin"><strong>90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years, </strong>Cancer Med</p><p class="text-muted"><small>Published on: Jun 01, 2016</small></p><div class="mop-wrapper"><p><strong>Authors</strong>: Casadei B, Pellegrini C, Pulsoni A, Annechini G, De Renzo A, Stefoni V, Broccoli A, Gandolfi L, Quirini F, Tonialini L, Morigi A, Argnani L, Zinzani PL</p>
</div></div></li></ul></div></div></div></div></div></section></div></div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.0/jquery.min.js"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.6/js/bootstrap.min.js"></script><script>$(function () {
  var toggleFloatingMenu = function() {
    $( '.js-floating-nav' ).toggleClass( 'is-visible' );
    $( '.js-floating-nav-trigger' ).toggleClass( 'is-open' );
  };

  $( ".background-card" ).css( "min-height", window.screen.availHeight + "px" );
  $( "[data-toggle=tooltip]" ).tooltip();
  $( '.js-floating-nav-trigger' ).on( 'click', function(e) {
    e.preventDefault();
    toggleFloatingMenu();
  });
  $( '.js-floating-nav a' ).on( 'click', toggleFloatingMenu );

  $("#remaining-profiles").on('show.bs.collapse', function() {
    $( '.js-profiles-collapse > i' )
      .removeClass( 'icon-chevron-down' )
      .addClass( 'icon-chevron-up' );
  });

  $("#remaining-profiles").on('hidden.bs.collapse', function() {
    $( '.js-profiles-collapse > i' )
      .removeClass( 'icon-chevron-up' )
      .addClass( 'icon-chevron-down' );
  });
});
</script><script>WebFontConfig = {
  google: { families: [ 'Lato:300,400,700:latin' ] }
};
(function() {
  var wf = document.createElement('script');
  wf.src = ('https:' == document.location.protocol ? 'https' : 'http') +
    '://ajax.googleapis.com/ajax/libs/webfont/1/webfont.js';
  wf.type = 'text/javascript';
  wf.async = 'true';
  var s = document.getElementsByTagName('script')[0];
  s.parentNode.insertBefore(wf, s);
})();</script></body></html>